Research / ULBI / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-035475 General Corporate
Debt relative to revenue 100th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.debt_to_revenue
115.97% · OPTIONAL · VALID
Capex intensity 87th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.29% · OPTIONAL · VALID
Operating cash generation 47th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
0.46% · OPTIONAL · VALID
Revenue growth 73th Own-history percentile · N=11
Evidence method Yoy · gp.fundamentals.revenue
21.51% · CORE · VALID
Inventory pressure 73th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
121.62% · OPTIONAL · VALID
Gross margin 7th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.gross_margin
22.18% · CORE · VALID
Operating margin 0th Own-history percentile · N=15
Evidence method Level · gp.fundamentals.operating_margin
-2.19% · CORE · VALID
R&D intensity 93th Own-history percentile · N=15
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.58% · OPTIONAL · VALID
SBC intensity 79th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 19 states Self-history eligible
Dec 31, 2021 0/8 normalized Level 3 Mar 31, 2022 0/8 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Dec 31, 2022 0/9 normalized Level 3 Mar 31, 2023 0/9 normalized Level 3 Jun 30, 2023 0/9 normalized Level 3 Sep 30, 2023 0/9 normalized Level 3 Dec 31, 2023 7/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 104.92%
Current 115.97%
Delta 11.06% Capex Intensity Increased
Previous 2.27%
Current 2.29%
Delta 0.03% Cash Generation Decreased
Previous 12.22%
Current 0.46%
Delta -11.77% Growth Increased
Previous 12.98%
Current 21.51%
Delta 8.53% Inventory Pressure Increased
Previous 104.15%
Current 121.62%
Delta 17.47% Margin Decreased
Previous 23.89%
Current 22.18%
Delta -1.71% Profitability Decreased
Previous 4.65%
Current -2.19%
Delta -6.84% R And D Intensity Increased
Previous 4.77%
Current 6.58%
Delta 1.81% Sbc Intensity Increased
Previous 0.48%
Current 0.54%
Delta 0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.